Vice President and Global Development Lead, Enfortumab Vedotin (PADCEV) Program @ Seagen
Vice President, Head of Immuno-Oncology and Late Stage Portfolio in Clinical Development @ Seagen
Global Clinical Lead in Clinical Development (Product Development) - Oncology @ Genentech
Global Filing Lead in Clinical Development (Product Development) - Oncology @ Genentech
Medical Director, Clinical Development (Product Development) - Oncology @ Genentech
Senior Medical Director, U.S. Medical Affairs BioOncology @ Genentech
Medical Director, U.S. Medical Affairs BioOncology @ Genentech
Oyewale Abidoye's Education
University of Chicago - The Pritzker School of Medicine
M.D. (Hematology, Medical Oncology)
2004 - 2007
Tufts University
M.D. (Internal Medicine)
2001 - 2004
Tufts University
M.D. (Adult Psychiatry)
2000 - 2001
Temple University
MPH (Biostatistics and Clinical Research)
1998 - 2000
College of Medicine, University of Lagos
M.B.B.S. (Bachelor of Medicine, Bachelor of Surgery)
1991 - 1996
University of Lagos
B.S. (Hons) (Preliminary Medical Sciences)
1990 - 1991
King College Lagos
Advanced level degree (Biology, Chemistry, and Physics)
1988 - 1990
Oyewale Abidoye's Skills
Clinical Research
Oncology
Clinical Trials
Internal Medicine
Cancer
Healthcare
Medical Education
Translational Research
Hematology
Transplant
Oyewale Abidoye's Summary
Oyewale Abidoye, based in California, United States, is currently a Senior Vice President, Oncology Therapeutics at Gilead Sciences, bringing experience from previous roles at AbbVie, Gilead Sciences and Seattle Genetics. Oyewale Abidoye holds a 2004 - 2007 M.D. in Hematology, Medical Oncology @ University of Chicago - The Pritzker School of Medicine. With a robust skill set that includes Clinical Research, Oncology, Clinical Trials, Internal Medicine, Cancer and more, Oyewale Abidoye contributes valuable insights to the industry. Oyewale Abidoye has 3 emails and 1 mobile phone number on RocketReach.